Clinical trial
Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or…
NCT00014339 · Medsearch, Industry · Unknown status
Key facts
| NCT number | NCT00014339 |
|---|---|
| Title | Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma |
| Official title | A Randomized, Phase III, Placebo-Controlled Multicenter Study to Demonstrate the Effectiveness and Safety of the Combination Enzyme Tablet (Wobe-Mugos E) as Adjuvant Therapy to Standard of Care Treatment in Patients With Stages II or III Multiple Myeloma |
| Lead sponsor | Medsearch, Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Drug, Procedure |
| Interventions | Wobe-Mugos E, melphalan, prednisone, quality-of-life assessment |
| Start date | Mar 1, 2000 |
| First posted | Feb 26, 2004 |
| Last update posted | Dec 18, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: